Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry

Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry

Abstract Background The objectives of this study were to describe the profile of ankylosing spondylitis (AS) patients treated with either infliximab (IFX) or subcutaneous golimumab (GLM) treatment in Canadian routine care setting along with assessing long-term effectiveness and safety. Methods AS pa...

Full description

Bibliographic Details
Main Authors: Proton Rahman, Michael Starr, Derek Haaland, Louis Bessette, Michelle Teo, Emmanouil Rampakakis, Allen J. Lehman, Francois Nantel
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Rheumatology
Subjects:
Ankylosing spondylitis
Axial spondyloarthritis
Registry
Infliximab
Golimumab
Effectiveness
Online Access:http://link.springer.com/article/10.1186/s41927-020-00158-z

Internet

http://link.springer.com/article/10.1186/s41927-020-00158-z

Similar Items